metoclopramide has been researched along with Tourette Syndrome in 6 studies
Metoclopramide: A dopamine D2 antagonist that is used as an antiemetic.
metoclopramide : A member of the class of benzamides resulting from the formal condensation of 4-amino-5-chloro-2-methoxybenzoic acid with the primary amino group of N,N-diethylethane-1,2-diamine.
Tourette Syndrome: A neuropsychological disorder related to alterations in DOPAMINE metabolism and neurotransmission involving frontal-subcortical neuronal circuits. Both multiple motor and one or more vocal tics need to be present with TICS occurring many times a day, nearly daily, over a period of more than one year. The onset is before age 18 and the disturbance is not due to direct physiological effects of a substance or another medical condition. The disturbance causes marked distress or significant impairment in social, occupational, or other important areas of functioning. (From DSM-IV, 1994; Neurol Clin 1997 May;15(2):357-79)
| Excerpt | Relevance | Reference |
|---|---|---|
| "To investigate the effects of metoclopramide on the intelligence and memory in patients with Tourette syndrome." | 9.10 | [Effects of metoclopramide on intelligence and memory in patients with Tourette syndrome]. ( Xie, XL; Ye, HC; You, Y, 2003) |
| "To investigate the effects of metoclopramide on the intelligence and memory in patients with Tourette syndrome." | 5.10 | [Effects of metoclopramide on intelligence and memory in patients with Tourette syndrome]. ( Xie, XL; Ye, HC; You, Y, 2003) |
| "Metoclopramide was started at 5 mg daily and titrated as needed to a maximum dose of 40 mg daily." | 2.71 | A randomized, double-blind, placebo-controlled trial of metoclopramide for the treatment of Tourette's disorder. ( Castellanos, FX; Craven-Thuss, B; McKinlay, BD; Nicolson, R; Smith, J, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ye, HC | 1 |
| Xie, XL | 1 |
| You, Y | 1 |
| Acosta, MT | 1 |
| Castellanos, FX | 2 |
| Nicolson, R | 1 |
| Craven-Thuss, B | 1 |
| Smith, J | 1 |
| McKinlay, BD | 1 |
| Berlin, CM | 1 |
| Desai, AB | 1 |
| Doongaji, DR | 1 |
| Satoskar, RS | 1 |
| Smirnov, AIu | 1 |
1 review available for metoclopramide and Tourette Syndrome
| Article | Year |
|---|---|
Advances in pediatric pharmacology and toxicology.
Topics: Animals; Anti-Bacterial Agents; Aspirin; Attention Deficit Disorder with Hyperactivity; Biological A | 1983 |
3 trials available for metoclopramide and Tourette Syndrome
| Article | Year |
|---|---|
[Effects of metoclopramide on intelligence and memory in patients with Tourette syndrome].
Topics: Adolescent; Adult; Child; Child, Preschool; Female; Humans; Intelligence; Male; Memory; Metocloprami | 2003 |
A randomized, double-blind, placebo-controlled trial of metoclopramide for the treatment of Tourette's disorder.
Topics: Adolescent; Child; Chronic Disease; Diagnostic and Statistical Manual of Mental Disorders; Dopamine | 2005 |
[Use of metoclopramide (cerucal) in Tourette syndrome].
Topics: Adolescent; Antipsychotic Agents; Child; Clinical Trials as Topic; Female; Humans; Male; Metoclopram | 1989 |
2 other studies available for metoclopramide and Tourette Syndrome
| Article | Year |
|---|---|
Use of the "inverse neuroleptic" metoclopramide in Tourette syndrome: an open case series.
Topics: Adolescent; Antipsychotic Agents; Child; Humans; Male; Metoclopramide; Middle Aged; Tourette Syndrom | 2004 |
metoclopramide in Gilles de la Tourette's syndrome (a case report).
Topics: Adult; Humans; Male; Metoclopramide; Tourette Syndrome | 1983 |